Innovation in Advanced Diagnostics: Neurology, Genetics, and Genomics

Wednesday, September 29, 10:15 - 11:15 a.m.
Exhibit Hall, Theater 2
Supported by Quest Diagnostics


Join our industry workshop to meet and hear from 2 of Quest Diagnostics’ elite scientific leaders about new, cutting-edge advanced diagnostics and capabilities. During the presentation you will learn more about new tests in development at Quest focused in the areas of neurology, oncology, and women’s health and how we are approaching health system, clinician, and patient needs tied to genetics testing.


After attending this session, participants will be able to:

  • Identify the newest cutting-edge advanced diagnostics tests and capabilities within the laboratory.
  • Understand the scientific background and major benefits to clinicians and patients.


Nigel J. Clarke, PhD
Vice President, R&D, Core Diagnostics and Technology Development
Quest Diagnostics
Secaucus, NJ

Felicitas L. Lacbawan, MD, FCAP (AP, CP, MGP), FACMG (CG)
Executive Medical Director Advanced Diagnostics, CMO Genetics and Genomics
Quest Diagnostics